NCT03226652

Brief Summary

This study aims to determine the prevalence and prognosis of heart failure with preserved ejection function (HFpEF) among patients being assessed for sleep disordered breathing (SDB).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 24, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

July 24, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

February 17, 2021

Completed
Last Updated

February 17, 2021

Status Verified

February 1, 2021

Enrollment Period

1.7 years

First QC Date

July 20, 2017

Results QC Date

January 21, 2021

Last Update Submit

February 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Unrecognised Heart Failure With Preserved Ejection Fraction (HFpEF) in Cohort With Clinically Suspected Sleep Disordered Breathing (SDB)

    The diagnosis of HFpEF was established using criteria set out in the European Society for Cardiology (ESC) guidelines based on clinical symptoms and/or signs, biomarker analysis (NT-proBNP) and evidence of structural cardiac remodeling or diastolic dysfunction on transthoracic echocardiography.

    Baseline

Study Arms (1)

Patients with clinically suspected sleep disordered breathing (SDB)

Patients referred for Sleep disordered breathing assessment.

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred from primary and secondary care for SDB assessment.

You may qualify if:

  • Aged ≥40 years and referred for respiratory polygraphy

You may not qualify if:

  • Previous diagnosis of Heart Failure
  • Treated sleep disordered breathing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Brompton Hospital

London, SW3 6NP, United Kingdom

Location

MeSH Terms

Conditions

Sleep Apnea SyndromesSleep Apnea, ObstructiveSleep Apnea, CentralHeart Failure

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesHeart DiseasesCardiovascular Diseases

Results Point of Contact

Title
Professor M Cowie
Organization
Imperial College London

Study Officials

  • Martin R Cowie, MD MSc

    Imperial College London

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2017

First Posted

July 24, 2017

Study Start

July 24, 2017

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

February 17, 2021

Results First Posted

February 17, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations